HRAS rs1801391: Understanding This Genetic Variant
The rs1801391 variant is a single nucleotide polymorphism located within the HRAS gene, a critical component of cellular signaling pathways. Research has evaluated this variant for potential associations with susceptibility to certain cancers, though current evidence remains limited.
What each genotype means
Common HRAS variant profile
This genotype represents the most common form of the HRAS gene at this position. Research into this variant has explored its potential role in modulating susceptibility to certain cancers, such as bladder cancer, though the evidence remains limited and findings are not definitive. This result does not constitute a medical diagnosis or a prediction of disease.
This is the most frequent genotype in most global populations, consistent with a minor allele frequency of approximately 0.08 for the C allele.
HRAS variant carrier
As a carrier of one copy of the C allele, you possess a variation that has been investigated for its potential association with bladder and thyroid cancer risk. Current scientific evidence is limited and mixed, meaning this genotype is not a reliable indicator of individual cancer risk. You should discuss any concerns about personal or family health history with a qualified healthcare professional.
Carried by roughly 1 in 7 people of European ancestry, with frequencies varying across other global populations.
HRAS variant homozygous
This genotype indicates you carry two copies of the C allele, which has been studied for its potential influence on bladder and thyroid cancer susceptibility. Because the evidence strength for this association is limited, it is unclear how this genotype impacts your personal health. This information should not be used to make medical decisions or to assess individual disease risk.
This is the least common genotype, occurring in a small percentage of the population consistent with a minor allele frequency of approximately 0.08.
What is rs1801391?
The variant rs1801391 is a specific genetic change, or single nucleotide polymorphism (SNP), located within the HRAS gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This particular variant is found in the exonic region of the gene, meaning it sits within the portion of the DNA that provides instructions for building proteins. Because it is located in a coding region, researchers have investigated whether this change might alter the structure or function of the resulting protein. Geneticists track these variants to understand how they might influence biological traits or disease risk. While many SNPs are benign and have no impact on health, others are studied for their potential to modulate how our cells function, grow, or respond to environmental factors.
The Role of the HRAS Gene
The HRAS gene provides instructions for making a protein called H-Ras, which is a member of the RAS family of proteins. These proteins act as molecular switches, cycling between an active state (bound to GTP) and an inactive state (bound to GDP) to regulate essential cellular processes. These processes include cell proliferation, differentiation, and survival. Because H-Ras is so central to controlling when a cell should grow or divide, it is classified as a proto-oncogene. When the HRAS gene functions normally, it helps maintain healthy cellular activity. However, mutations or misregulation of this gene can disrupt these signaling pathways, which is why HRAS is frequently studied in the context of oncology. Understanding how variants like rs1801391 interact with this pathway is a focus of ongoing molecular research.
Research and Evidence Strength
Scientific interest in rs1801391 has primarily centered on its potential role in modulating susceptibility to specific types of cancer, including bladder and thyroid cancers. However, it is important to note that the evidence linking this specific variant to these conditions is currently classified as limited. In genetic research, a statistical association does not necessarily imply causation. Many factors, including other genetic variants, lifestyle, and environmental exposures, contribute to cancer risk. While some studies have explored this variant, the findings have not consistently demonstrated a strong or definitive clinical impact. Consequently, this variant is not currently used as a diagnostic tool or a reliable predictor of disease. The scientific community continues to evaluate such variants to determine if they play a meaningful role in human health or if they are simply neutral variations in the human genome.
Population Frequency
Genetic variants are distributed differently across various ancestral groups, and understanding these frequencies is essential for interpreting genetic data. For rs1801391, the minor allele frequency (MAF) is approximately 0.08 in European populations. This means that the variant is relatively common in this group, appearing in a significant portion of the population. Frequency data is typically derived from large-scale databases like the Genome Aggregation Database (gnomAD), which aggregates sequencing data from diverse individuals worldwide. Because allele frequencies can vary significantly between different ethnic and geographic populations, researchers often emphasize the importance of considering ancestry when evaluating the potential significance of any genetic variant.
What This Information Means for You
If you have encountered information about the rs1801391 variant, it is important to maintain a balanced perspective. Because the evidence linking this variant to health outcomes is limited and not clinically validated, it should not be used to make medical decisions or to assess personal disease risk. Genetic variants are only one piece of a very complex puzzle that includes your overall health history, lifestyle, and environment. You cannot change your genetic code, but you can focus on evidence-based health practices, such as regular screenings and maintaining a healthy lifestyle, which are far more impactful on your long-term well-being. If you have specific concerns about your genetic profile or family history of cancer, the most appropriate step is to consult with a qualified healthcare provider or a genetic counselor who can provide personalized guidance based on your unique clinical context.
How common is this variant?
The rs1801391 variant has a minor allele frequency of approximately 0.08 in European populations, making it a relatively common genetic variation.
Frequently asked questions
Is rs1801391 a cause of cancer?
No, rs1801391 is not considered a direct cause of cancer. While it has been studied for potential associations with cancer susceptibility, the current evidence is limited and does not establish a causal link.
Should I get tested for the HRAS rs1801391 variant?
There is no clinical recommendation to test for this variant. Because it lacks strong clinical significance, testing would not provide actionable information for your healthcare management.
Can I change my HRAS genotype?
No, your genetic sequence is inherited from your parents and remains constant throughout your life. You cannot change your genotype, but you can manage your health through lifestyle choices and regular medical check-ups.
Where can I find more information about HRAS?
You can find reliable information about the HRAS gene and its functions on resources like MedlinePlus Genetics or the NCBI Gene database. These sites provide comprehensive, peer-reviewed summaries of human genes.
Sources & further reading
Educational information only, last refreshed 9/20/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1801391?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29